Waldenström's macroglobulinemia historical perspective: Difference between revisions
No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
==Historical Perspective== | ==Historical Perspective== | ||
Waldenström's macroglobulinemia was first discovered by Jan G. Waldenström, a Swedish oncologist in 1944 | *Waldenström's macroglobulinemia was first discovered by Jan G. Waldenström, a Swedish oncologist in 1944. | ||
* Two of the patients presented with bleeding from the nose and mouth, anemia, decreased levels of fibrinogen in the blood (hypofibrinogenemia), swollen lymph nodes, neoplastic plasma cells in bone marrow, and increased viscosity of the blood due to increased levels of a class of heavy proteins called macroglobulins.<ref name="HP">Waldenström's macroglobulinemia. Wikipedia (2015)https://en.wikipedia.org/wiki/Waldenström%27s_macroglobulinemia#Pathophysiology Accessed on November 6, 2015</ref> | |||
==References== | ==References== |
Revision as of 17:08, 16 November 2015
Waldenström's macroglobulinemia Microchapters |
Differentiating Waldenström's macroglobulinemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Waldenström's macroglobulinemia historical perspective On the Web |
American Roentgen Ray Society Images of Waldenström's macroglobulinemia historical perspective |
FDA on Waldenström's macroglobulinemia historical perspective |
CDC on Waldenström's macroglobulinemia historical perspective |
Waldenström's macroglobulinemia historical perspective in the news |
Blogs on Waldenström's macroglobulinemia historical perspective |
Directions to Hospitals Treating Waldenström's macroglobulinemia |
Risk calculators and risk factors for Waldenström's macroglobulinemia historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mirdula Sharma, MBBS [2]
Overview
Waldenström's macroglobulinemia was first discovered by Jan G. Waldenström, a Swedish physician in 1944.[1]
Historical Perspective
- Waldenström's macroglobulinemia was first discovered by Jan G. Waldenström, a Swedish oncologist in 1944.
- Two of the patients presented with bleeding from the nose and mouth, anemia, decreased levels of fibrinogen in the blood (hypofibrinogenemia), swollen lymph nodes, neoplastic plasma cells in bone marrow, and increased viscosity of the blood due to increased levels of a class of heavy proteins called macroglobulins.[1]
References
- ↑ 1.0 1.1 Waldenström's macroglobulinemia. Wikipedia (2015)https://en.wikipedia.org/wiki/Waldenström%27s_macroglobulinemia#Pathophysiology Accessed on November 6, 2015